AG00IKI7

59865-13-3 | Cyclosporin A

Chemical structure of Cyclosporin A, CAS 59865-13-3
AG00IKI7
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 59865-13-3
Catalog Number AG00IKI7(AGN-PC-0STVLH)
Chemical Name Cyclosporin A
EC Number 611-907-1
IUPAC Name (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
InChI InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1
InChI Key PMATZTZNYRCHOR-CGLBZJNRSA-N
MDL Number MFCD00274558
Molecular Formula C62H111N11O12
Molecular Weight 1202.6112
SMILES O=C(C(C(C)C)N(C)C(C(CC(C)C)N(C)C(C(CC(C)C)N(C)C1=O)=O)=O)N(C)C([C@H](O)[C@H](C)C/C=C/C)C(NC(CC)C(N(C)CC(N(C)C(CC(C)C)C(NC(C(C)C)C(N(C)C(C(NC(C)C(N[C@@H]1C)=O)=O)CC(C)C)=O)=O)=O)=O)=O
UNII 83HN0GTJ6D
Synonyms
Ciclosporin, CsA Neoral, CsA-Neoral, CsANeoral, CyA NOF, CyA-NOF, Cyclosporin, Cyclosporin A, Cyclosporine, Cyclosporine A, Neoral, OL 27 400, OL 27-400, OL 27400, Sandimmun, Sandimmun Neoral, Sandimmune, cyclosporin A, cyclosporine, Ciclosporin, 59865-13-3, Cyclosporine A, Ciclosporine, Neoral, Cyclosporin, Ciclosporina, Ciclosporinum, Sandimmune, Equoral, Neoplanta, Sandimmun, Sang-35, Gengraf, Sandimmun Neoral, UNII-83HN0GTJ6D, Antibiotic S 7481F1, Consupren, Restasis, Ramihyphin A, SangCyA, MFCD00274558, 83HN0GTJ6D, MLS001333756, CHEBI:4031, CSA, S-Neoral, Cipol N, Sigmasporin Microoral, Sang 35, DSSTox_CID_365, Ciclosporine [INN-French], Ciclosporinum [INN-Latin], Ciclosporina [INN-Spanish], Ciclosporin (Ciclosporin A), DSSTox_RID_75541, DSSTox_GSID_20365, SDZ-OXL 400, OL 27-400, CCRIS 1590, HSDB 6881, Abrammune, Imusporin, Seciera, Vekacia, DRG-0275, Papilock Mini, Arpimune ME, Zinograf ME, Sandimmune Neoral, C62H111N11O12, NSC 290193, Ciclosporina Germed, S 7481F1, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, CYA, SMR000058578, Cicloral (antibiotic), Debio088, 79217-60-0, Cyclosporine [USAN:USP], Sigmasporin, Cyclokat, Mitogard, Papilock, Pulminiq, Zyclorin, CicloMulsion, CyclosporinA, Ciclosporin DT, Consupren S, NSC290193, Modusik-A, NeuroSTAT, 1cyn, 2wfj, 4jjm, Cipol-N, NCGC00016890-01, Neoral, Sandimmune, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19, (R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl), Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl), Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl), Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl], Prestwick_731, Ciclosporin [INN], CAS-59865-13-3, CsA & IFN.alpha., 1c5f, 2z6w, Prestwick2_000435, Prestwick3_000435, CHEMBL160, Sang-2000, AC1NR4C4, SCHEMBL3491, SCHEMBL4442, Nova-22007, Ikervis (opthalmic solution), BSPBio_000450, Cyclosporin A & IFN.alpha., MLS000028376, MLS002153454, MLS002207033, Verkazia (opthalmic solution), Cyclosporin-A(Cyclosporine-A), BPBio1_000496, GTPL1024, DTXSID0020365, CHEBI:92233, AOB2581, ATH-002, OLO-400, CB-01-09 MMX, PMATZTZNYRCHOR-CGLBZJNRSA-N, HMS1569G12, HMS2089A09, HMS2096G12, HMS2230M14, HMS3713G12, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl), 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine], 30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone, 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl), Tox21_110667, Tox21_301849, BDBM50022815, DE-076, ST-603, Cyclosporin A, >=98.5% (TLC), AKOS015969287, Tox21_110667_1, CCG-208184, DB00091, EBD2126862, KS-1257, NCGC00093704-12, NCGC00164258-01, NCGC00164258-02, NCGC00164258-03, NCGC00255232-01, AT-12519, C042, OL-27400, SBI-0050230.P003, AB0090560, 5946-EP0930075A1, 5946-EP2289877A1, 5946-EP2292601A1, 5946-EP2292602A1, 5946-EP2292603A1, 5946-EP2292604A2, 5946-EP2292618A1, 5946-EP2293650A1, 5946-EP2298737A1, 5946-EP2298739A1, 5946-EP2298740A1, 5946-EP2298741A1, 5946-EP2298771A2, 5946-EP2301920A1, 5946-EP2301940A1, 5946-EP2308843A1, 5946-EP2308861A1, J10181, J90049, 865C133, Cyclosporin A, VETRANAL(TM), analytical standard, SR-01000780563, BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA, BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA, Q-200913, SR-01000780563-3, BRD-K03222093-001-01-8, BRD-K13533483-001-03-0, Ciclosporin, European Pharmacopoeia (EP) Reference Standard, Cyclosporin A, from Tolypocladium inflatum, >=95% (HPLC), solid, Cyclosporine, United States Pharmacopeia (USP) Reference Standard, Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard, Cyclosporin A, from Tolypocladium inflatum, BioReagent, for molecular biology, >=95%, Cyclosporine, Pharmaceutical Secondary Standard; Certified Reference Material, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,1, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone, (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone, 30-Ethyl-33-((E)-1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone, Cicloral, Optimmune, Ciclosporina A, CsANeoral, Cyclosporin H, CsA Neoral, CsA-Neoral, Ciclosporine [INN], CyA NOF, CyA-NOF, Cyclosporine [USAN], Cyclopropylboronic acid, Cyclosporine A/B/C/D/H, ACN-029253, CID5284373, CS-O-06250, Ciclosporin (Cyclosporin A; Cyclosporine), OL 27400, C62-H111-N11-O12, OL 27 400, B1922, C2408, A10260, D016572, Cyclosporin A, 99%, an immunosuppressive agent - 1G 1g, ,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, 9,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone, 55126-45-9,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited